|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:416-422
© 2005 The American Association for Thoracic Surgery
Cardiothoracic Transplantation |
a Department of Paediatric Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
b Department of Paediatric Anaesthesiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
c Department of Paediatric Cardio-thoracic Anaesthesiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
d Transplant Coordinator, the Department of Cardio-Thoracic Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom
e Department of Cardiac Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom
f Department of Paediatric Cardiac Surgery, Freeman Hospital, Newcastle upon Tyne, United Kingdom
Received for publication April 26, 2004; revisions received June 10, 2004; accepted for publication June 14, 2004. * Address for reprints: Milind Chaudhari, MD, Freeman Hospital, Newcastle upon Tyne, NE 7 7DN, United Kingdom (E-mail: milind.chaudhari{at}nuth.northy.nhs.uk).
| Abstract |
|---|
|
|
|---|
METHODS: We performed a retrospective review. Between 1985 and 2003, 6 children aged less than 16 years were referred for cardiac transplantation. The indication for cardiac transplantation was end-stage cardiac failure early after the completion of the Fontan-type operation.
RESULTS: All 6 patients listed for transplantation underwent cardiac transplantation; the median interval to transplantation from the operation was 36 days (range, 6-180 days). Four patients had undergone the Fontan procedure, and 2 had one-and-a-half-ventricle repair. All 6 patients were ventilated and inotrope dependant, with varying degrees of multiorgan dysfunction. One patient was bridged to transplantation with extracorporeal membrane oxygenation. The median age at transplantation was 7.1 years (range, 3-12.5 years), and weight was 18.9 kg (range, 11-35 kg). One patient died on the operating table (graft failure and hemorrhage). In 5 survivors the median intensive care unit stay was 10 days (range, 8-61 days). On follow-up of 6 to 81 months, there have been no subsequent deaths, and the quality of life in survivors is good.
CONCLUSION: Rescue cardiac transplantation in the setting of an early failure of the Fontan-type circulation and end-stage cardiac failure is an effective treatment option and can be performed with acceptable early mortality and encouraging short-term to medium-term results.
|
Cardiac transplantation in infants and children has evolved considerably over the past 2 decades.1-5 Five-year survival is currently approaching 90% in the cardiomyopathy group and 80% in those with congenital heart disease as a primary diagnosis.1,4,6 In 1971, the Fontan procedure was initially conceived for a patient with tricuspid atresia.7 Since then, it has been established as a definitive palliation for cardiac anomalies with a single functional ventricle or 2 ventricles with anatomy unsuitable for biventricular repair.8-10 Early failure of the Fontan circulation within 30 days of an operation is a potentially fatal complication.11,12 The conventional approach in this situation is to take down the Fontan circulation. This approach, however, is associated with very high mortality and an uncertain long-term future.11,12 An alternative strategy of cardiac transplantation as a life-saving and life-enhancing therapy seems attractive because it provides normal cardiac anatomy and physiology. Cardiac transplantation for late failure of the Fontan circulation has been reported previously, with variable success.4,13-16 Indications for transplantation in this group are protein-losing enteropathy, intractable atrial arrhythmia, and systemic ventricular dysfunction. Early failure of the Fontan-type circulation is a life-threatening complication, and the therapeutic options are limited. To our knowledge, this is the first series of rescue cardiac transplantation for early failure of the Fontan-type circulation in children. Technical challenges in peritransplant intensive care and cardiac transplantation surgery are discussed.
| Patients and methods |
|---|
|
|
|---|
Patient characteristics
Table 1 summarizes the clinical and hemodynamic data on these patients. Four patients had undergone a modified Fontan operation, and the remaining 2 patients had undergone a one-and-a-half-ventricle repair operation. All 6 patients were separated from cardiopulmonary bypass after completion of the operation. Four patients (patients 2, 3, 5, and 6) were referred for cardiac transplantation after failure in weaning off ventilatory and inotropic support and progressive cardiac failure in the early postoperative period. Patients 1 and 4 were noted to have severe systemic ventricular dysfunction with significant systemic atrioventricular valve regurgitation in the early postoperative period. Onset of intractable atrial arrhythmias in patient 1 and superior vena caval hypertension syndrome in patient 4 led to end-stage cardiac failure and referral for cardiac transplantation. All 6 patients received a cardiac transplant; the median interval from operation to transplantation was 36 days (range, 6-180 days). There were no deaths while waiting on the transplant list after early failure of the Fontan-type circulation.
|
|
|
| Results |
|---|
|
|
|---|
|
| Discussion |
|---|
|
|
|---|
In the current era, creation of smaller aortopulmonary shunts, attention to systemic outflow tract obstruction and atrioventricular valve regurgitation, staging of the Fontan procedure, extracardiac Fontan modification, routine use of fenestration, and modified ultrafiltration during cardiopulmonary bypass are the strategies responsible for the significant decrease in the incidence of early Fontan failures, despite a widening application of the Fontan procedure to high-risk patients.11,12,17,18
Pre-Fontan hemodynamic assessment
Early failure of the Fontan-type operations, despite apparently satisfactory preoperative assessment, highlights the limitations of the techniques of hemodynamic and ventricular function assessment in these patients. Current techniques of hemodynamic assessment in this group of patients are often limited by low pulmonary blood flow and do not allow assessment of pulmonary vasculature under different loading conditions. M-mode and cross-sectional echocardiography are conventionally used to evaluate ventricular volume and function, and their accuracy depends on the ability to obtain a desired cross-sectional view and accurate geometric volume assumption. They are of limited value in the context of a functioning single ventricle because of complex structural geometry and numerous variations in the ventricular morphology. Stumper and colleagues19 have proposed a catheter technique to provide a 2-point hemodynamic assessment of the pulmonary vasculature before the Fontan operation. Ventricular time-volume curves obtained by means of radionuclide angiography,20 magnetic resonance imaging,21 or real-time 3-dimensional echocardiography22 are likely to provide reliable quantitative data on the global ventricular performance in the future.
Management of early Fontan failure
The pathophysiology of the early failure of the Fontan circulation is characterized by a combination of increased systemic venous pressure and a low cardiac output state. This initiates a cascade of events that results in tissue edema, hypoxia, and organ hypoperfusion, culminating in multiorgan failure and death. Early cardiac catheterization is mandatory to exclude fenestration occlusion, obstruction to the cavopulmonary pathways, and assessment of transpulmonary gradient.
Our ventilation strategy was aimed at maintenance of functional residual capacity while minimizing mean airway pressure to keep pulmonary vascular resistance at as low a level as possible, thereby optimizing pulmonary blood flow and ventricular preload. Three patients in this series also received nitric oxide. Pleural and peritoneal effusions reduce chest compliance and were aggressively drained. We preferred a combination of phosphodiesterase inhibitor (milrinone) and a catecholamine (dobutamine or epinephrine) for inotropic support in these patients. Milrinone has been shown to have beneficial effects after pediatric cardiac surgery and has favorable effects on pulmonary vascular resistance.23 Minimizing exogenous use of catecholamine might have particular benefit for these patients in view of the adverse effects of catecholamines on splanchnic blood flow,24 as well as adrenoreceptor downregulation before transplantation. Multiorgan dysfunction can manifest as renal failure, gastrointestinal dysfunction, and hepatic dysfunction necessitating meticulous multidisciplinary intensive care management. We recommend early use of parenteral nutrition in combination with low-dose trophic volumes of enteral feeding and selective decontamination of the digestive tract to prevent gastrointestinal malfunction. Tissue hypoxia, edema, and loss of proteinaceous exudates render these patients susceptible to infection. A high degree of suspicion for sepsis is therefore required coupled with rigorous microbiologic surveillance.
Mechanical circulatory support for patients with failing Fontan circulation has been described.25,26 A recent report describes the use of extracorporeal membrane oxygenation as an effective mechanical circulatory support for patients with failing Fontan circulation.27 This approach can be used as a short-term resuscitative measure as a bridge to recovery. Alternatively, it can be used as a stabilization maneuver as a bridge to transplantation. Morbidity and mortality associated with mechanical support for the failing Fontan circulation is still substantial,25-27 and the outcome is particularly unfavorable in patients with progressive multisystem organ dysfunction. Patient 2 in our series was bridged to transplantation with extracorporeal membrane oxygenation. In addition, 2 other patient in our series were electively cooled to a core temperature of 34°C to 35°C to reduce systemic oxygen consumption when their own oxygen-delivery capability was severely compromised.
On the basis of the predominant mechanism for the failure, we suggest an algorithm for the management of early Fontan failure (Table 5). In our patients we decided to go down the cardiac transplantation route because the mechanism for the failure of the Fontan-type circulation was multifactorial, there were no other viable surgical options available, and the patients were in end-stage cardiac failure with progressive multisystem organ dysfunction.
|
Conclusion
Cardiac transplantation, although technically challenging, is an effective treatment option in the event of early failure of the Fontan-type circulation in children. Early referral for transplant assessment should be sought in the event of early failure of the Fontan-type circulation to avoid multiorgan dysfunctionrelated morbidity and mortality and to allow for procurement of a suitable donor heart.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. B. Pauliks and A. Undar Heart Transplantation for Congenital Heart Disease World Journal for Pediatric and Congenital Heart Surgery, October 1, 2011; 2(4): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Rood, S. A. Teele, C. S. Barrett, J. W. Salvin, P. T. Rycus, F. Fynn-Thompson, P. C. Laussen, and R. R. Thiagarajan Extracorporeal membrane oxygenation support after the Fontan operation J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, M. Plunkett, J. Lynch, X. Zhou, C. Ballard-Croft, and J. B. Zwischenberger Wang-Zwische Double-Lumen Cannula Leads to Total Cavopulmonary Support in a Failing Fontan Sheep Model Ann. Thorac. Surg., June 1, 2011; 91(6): 1956 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Irving, G. Parry, J. O'Sullivan, J. H. Dark, R. Kirk, D. S. Crossland, M. Chaudhari, M. Griselli, J. R. L. Hamilton, and A. Hasan Cardiac transplantation in adults with congenital heart disease Heart, August 1, 2010; 96(15): 1217 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gewillig, S. C. Brown, B. Eyskens, R. Heying, J. Ganame, W. Budts, A. L. Gerche, and M. Gorenflo The Fontan circulation: who controls cardiac output? Interact CardioVasc Thorac Surg, March 1, 2010; 10(3): 428 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sodian, S. Weber, M. Markert, M. Loeff, T. Lueth, F. C. Weis, S. Daebritz, E. Malec, C. Schmitz, and B. Reichart Pediatric cardiac transplantation: three-dimensional printing of anatomic models for surgical planning of heart transplantation in patients with univentricular heart. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1098 - 1099. [Full Text] [PDF] |
||||
![]() |
C. S.D. Almond, J. E. Mayer Jr, R. R. Thiagarajan, E. D. Blume, P. J. del Nido, and D. B. McElhinney Outcome After Fontan Failure and Takedown to an Intermediate Palliative Circulation Ann. Thorac. Surg., September 1, 2007; 84(3): 880 - 887. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |